# US 2010/0168126 A1 · Cosmetic Use of 1-Aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine Carbomamides and Related Compounds

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2010/0168126 A1
- Document ID: US20100168126A1
- Status: Published application
- Kind: A1
- Application number: 12/344,868
- Filed: 2008-12-29
- Published: 2010-07-01
- Earliest claimed: 2008-12-29
- Assignees: Avon Products, Inc.
- Inventors: Dmitri S. Ptchelintsev; Hong Hu; Gopinathan K. Menon; Kristine Schmalenberg; John W. Lyga
- Web page: https://patentgrep.com/patent/US20100168126A1

## CPC

- A61K 31/496: Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A61K 8/494: {with more than one nitrogen as the only hetero atom}
- A61P 17/00: Drugs for dermatological disorders
- A61Q 19/00: Preparations for care of the skin
- A61Q 19/08: Anti-ageing preparations
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

Cosmetic compositions comprising 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides and methods of using such compositions to impart anti-aging benefits to the skin are disclosed. The 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamides are believed to have modulatory activity against one or more biochemical pathways implicated in skin aging.

## Claims

### Claim 1

A method for providing a benefit to human skin comprising topically applying to the skin of an individual in need thereof an effective amount of a 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide or a cosmetically acceptable salt thereof in a cosmetically acceptable vehicle.

### Claim 2 (depends on 1)

The method according to claim 1 wherein said 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide has the structure of formula I:
where R1, R2, R3, R4, R5, R6, and R7 are independently hydrogen or a group —R9-R10;
R9 represents, independently at each occurrence, a bond; an aliphatic C1-C20 hydrocarbon radical; a C1-C20 aromatic hydrocarbon radical; or a C1-C20 heteroaryl radical;
R10 is selected independently at each occurrence from hydrogen; —F; —Cl; —Br; —I; —OH, —OR; —NH2; —NHR; —N(R)2; —N(R)3+; —N(R)—OH; —N(→O)(R)2; —O—N(R)2; —N(R)—O—R; —N(R)—N(R)2; —C═N—R; —N═C(R)2; —C═N—N(R)2; —C(═NR)—N(R)2; —SH; —SR; —CN; —NC; —CHO; —CO2H; —CO2−; —CO2R; —(C═O)—S—R; —O—(C═O)—H; —O—(C═O)—R; —S—(C═O)—R; —(C═O)—NH2; —(C═O)—N(R)2; —(C═O)—NHNH2; —O—(C═O)—NHNH2; —(C═S)—NH2; —(C═S)—N(R)2; —N(R)—CHO; —N(R)—(C═O)—R; —(C═NR)—O—R; —O—(C═NR)—R, —SCN; —NCS; —NSO; —SSR; —N(R)—C(═O)—N(R)2; —N(R)—C(═S)—N(R)2; —SO2—R; —O—S(═O)2—R; —S(═O)2—OR; —N(R)—SO2—R; —SO2—N(R)2; —O—SO3−; —O—S(═O)2—OR; —O—S(═O)—OR; —O—S(═O)—R; —S(═O)—OR; —S(═O)—R; —NO; —NO2; —NO3; —O—NO; —O—NO2; —N3; —N2; —N(C2H4); —Si(—R)3; —CF3; —O—CF3; —(C═O)—R; —PR2; —O—P(═O)(OR)2; —P(═O)(OR)2; ═O; ═S; ═NR; an aliphatic C1-C20 hydrocarbon radical; a C1-C20 aromatic hydrocarbon radical; or a C1-C20 heteroaryl radical;
where R is independently at each occurrence hydrogen or a saturated, partially saturated, or aromatic C1-C20 hydrocarbon radical or halogenated derivative thereof;
and where any two adjacent groups R1, R2, R3, R4, and R5 may, together with the phenyl ring to which they are attached, form a five-membered or six-membered aliphatic or aromatic ring, optionally substituted with one or more groups R10 and optionally including one or more heteroatoms selected from O, N, S in the ring.

### Claim 3 (depends on 2)

The method according to claim 2, where R1, R2, R4, and R5 represent hydrogen.

### Claim 4 (depends on 2)

The method according to claim 2, where R3 represents a group —OR.

### Claim 5 (depends on 4)

The method according to claim 4, where R3 represents —OCH3.

### Claim 6 (depends on 2)

The method according to claim 2, where R7 and R8 represent hydrogen.

### Claim 7 (depends on 2)

The method according to claim 2, where R6 is a group —(C═O)—R, where R is selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl, phenyl, toluyl, or benzyl.

### Claim 8 (depends on 7)

The method according to claim 7, where R6 is a group —(C═O)—(C6H5).

### Claim 9 (depends on 2)

The method according to claim 2, where R6 is a group —SO2—R, where R is selected from the group consisting of methyl, ethyl, propyl, butyl, pentyl, hexyl, phenyl, toluyl, or benzyl.

### Claim 10 (depends on 9)

The method according to claim 9, where R6 is a group —SO2—CH3.

### Claim 11 (depends on 11)

The method according to claim 11, wherein said skin benefit is selected from the group consisting of:
(a) treatment, reduction, and/or prevention of fine lines or wrinkles,
(b) reduction of skin pore size,
(c) improvement in skin thickness, plumpness, and/or tautness;
(d) improvement in skin suppleness and/or softness;
(e) improvement in skin tone, radiance, and/or clarity;
(f) improvement in procollagen and/or collagen production;
(g) improvement in maintenance and remodeling of elastin;
(h) improvement in skin texture and/or promotion of retexturization;
(i) improvement in skin barrier repair and/or function;
(j) improvement in appearance of skin contours;
(k) restoration of skin luster and/or brightness;
(l) replenishment of essential nutrients and/or constituents in the skin;
(m) improvement of skin appearance decreased by menopause;
(n) improvement in skin moisturization;
(o) increase in skin elasticity and/or resiliency; or
(p) treatment, reduction, and/or prevention of skin sagging.

### Claim 12 (depends on 11)

The method according to claim 11, wherein said skin benefit is the treatment, reduction, and/or prevention of fine lines or wrinkles.

### Claim 13 (depends on 11)

The method according to claim 11, wherein said skin benefit is the treatment, reduction, and/or prevention of skin sagging.

### Claim 14 (depends on 1)

The method according to claim 1, wherein said 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide has the structure:
or a cosmetically acceptable salt thereof.

### Claim 15 (depends on 1)

The method according to claim 1, wherein said 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide has the structure:
or a cosmetically acceptable salt thereof.

### Claim 16

A method for treating wrinkles and/or fine lines comprising topically applying to said wrinkle and/or fine line on the skin of an individual in need thereof an effective amount of a 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide or a cosmetically acceptable salt thereof in a cosmetically acceptable vehicle for a time sufficient to reduce the severity of said wrinkles of fine lines.

### Claim 17

A cosmetic composition comprising from about 0.0001% to about 25% by weight of a 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide in a cosmetically acceptable vehicle.

### Claim 18 (depends on 17)

The cosmetic composition according to claim 17, wherein said cosmetically acceptable vehicle comprises a water-in-oil or oil-in-water emulsion.

### Claim 19 (depends on 17)

The cosmetic composition according to claim 17, wherein said 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide has the structure:
or a cosmetically acceptable salt thereof.

### Claim 20 (depends on 17)

The cosmetic composition according to claim 17, wherein said 1-aroyl-N-(2-oxo-3-piperidinyl)-2-piperazine carboxamide has the structure:
or a cosmetically acceptable salt thereof.
